Welcome to the Institute of Clinical Research
Welcome to the Institute of Clinical Research
About Us
The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.
For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community. For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.
It is the membership that makes the Institute.
How does it all work ?
The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.
The Board is made up of members who give their time freely to guide the future direction of the ICR.
The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.
Our Mission
The ICR exists to support our members through all stages of their careers. We do this, in part, by:
- Defining and refining standards for our profession
- Providing a forum for discussion of key issues impacting clinical research
- Promoting good relations with other healthcare related groups
- Providing opportunities for learning and development to enhance professional competence
- Enhancing public confidence and understanding of clinical research
Current News
FDA rejects two China-developed cancer drugs
The Food and Drug Administration has refused to approve two cancer treatments developed by Chinese drugmakers, citing trial design in one rejection an…
University launches hub for pregnant women with pre-existing medical conditions
Norfolk and Norwich University Hospitals Foundation Trust opens centre to increase survival rate among pregnant women managing other conditions
Roche cancer immunotherapy fails another trial, casting doubt on emerging drug class
- A drug combination including Roche’s experimental immunotherapy tiragolumab failed one of two main goals in a Phase 3 trial in a common form of lung…
With 200M unused doses, AstraZeneca's COVID vaccine partner Serum Institute halts production
About 200 million doses of COVID-19 vaccine are gathering dust in warehouses of the world’s largest vaccine manufacturer as global demand ebbs.
How a surprise finding made an Alnylam study one of biotech’s most ‘polarizing’ trials
The outcome, no longer seen as a sure bet, could influence how future drugs for a deadly heart disease are developed.
DNA analysis uncovers new cancer treatment clues
Researchers were able to detect specific combinations of genetic alterations which may hold key to the growth of cancers
Troubling data leads a biotech to pull its prized drug from market and FDA review
- The New York-based biotechnology company TG Therapeutics has decided to pull its only approved medicine from the market, after recent clinical trial…
ISA Pharmaceuticals announce new trial testing technology for cancers
Trial of Amplivant will begin in a number of cancer patients including those with ovarian cancer
Inflation is forcing prioritization of healthcare spending — are you ready?
If you're a pharmaceutical marketer, you're about to face a challenge no US-based marketer has seen since the early 1990s: inflation.
UK patients granted early access for radioligand therapy in advanced prostate cancer
Advanced Accelerator Applications (AAA), a Novartis company, has announced that eligible patients in the UK have been granted early access for radioli…
A seasonal COVID-19 booster shot? Don't count on it in the US or Europe
People in the U.S. and Europe hoping to receive COVID-19 vaccine booster shots every four to six months are in for a rude awakening.
Hundreds of urothelial cancer patients to receive new treatment
NICE recommends avelumab as treatment for adults with locally advanced or metastatic urothelial cancer
In major shake-up, Novartis combines pharma and oncology units, leaving 3 top execs without jobs
Novartis CEO Vas Narasimhan is giving the Swiss pharma a huge makeover ahead of a possible spinoff of generics unit Sandoz, pushing out three C-level …
Yet another gene therapy developer turns to layoffs
- A Dallas-based gene therapy developer with a lengthy list of research projects has decided to prioritize two moving forward and, in doing so, will r…
Boehringer goes bold with 'unwearable' fashion to spotlight patients' rare skin disease pain
It feels like a paper cut, but multiplied by 10,000. Or being stabbed with a bunch of knives over and over again.
Stalicla completes phase 1b trials into precision medicine for autism spectrum disorder
STP1 has demonstrated good safety and tolerability profiles, while also showing positive results for neurological function
Swiss clinical stage biote…
UK’s first digital health training programme for all NHS frontline staff
The Digital Health Academy – which aims to help build the UK’s first digital-ready frontline workforce – is now open to health and care staff across t…
NHS contacting five million people for fourth COVID-19 vaccination
The NHS will begin giving a second booster vaccination to around five million people who are at a higher risk from COVID-19. Those who are aged over 7…
Omicron BA.2 variant triggers COVID-19 surge in England
The new sub-variant, named Deltacron, combines mutations from both Omicron and Delta. The variant has been detected in multiple areas of France, and c…
How Merck's 'puzzling' results could impact immunotherapy's role in early lung cancer
An immunotherapy from Merck & Co. is the latest drug of its kind to slow the return of lung cancer in clinical testing, though mixed results in th…
Course Postponements Due to Covid
All of our delegates and members who had course places postponed over the last two years due to covid restrictions/illness have now been contacted dir…
Useful Downloads
Events and Courses
GCP for Experts L10
This course provides an in-depth look at the regulatory systems currently in operation in the EU and their impact, together with UK legislation, ...
Essentials of Clinical Trial Monitoring L15
This practical course defines the role of the clinical research monitor and explains the interaction with others in key roles as part of the clinical ...
Data Management for Clinical Researchers L16
Are you a clinical researcher who has to review and approve data management plans, but find yourself struggling to know what you should be looking ...
Foundation in Good Clinical Practice (GCP) L13
This course provides an in-depth look at the regulatory systems currently in operation in the EU and their impact, together with UK legislation, on...
Effective Project Management for Clinical Trials (3 Days ) L17
This practical course provides delegates with basic project management techniques that can be applied to clinical trial project management. Learning i...
Clinical Trial Administration - Beyond the Basics L18
Clinical Trial Administrators are at the heart of any project team...
Current Jobs
Quick Links
The oldest independent membership-led professional body for clinical researchers across the globe.
Latest Posts
- FDA rejects two China-developed cancer drugs 19/05/2022 03:45 PM
- University launches hub for pregnant women with pre-existing medical conditions 19/05/2022 03:44 PM
- Roche cancer immunotherapy fails another trial, casting doubt on emerging drug class 19/05/2022 03:42 PM
Useful Links
Contact Us
Suite 11a, Cedar Court
Grove Park
White Waltham
Maidenhead
SL6 3LW
info@icr-global.org
Copyright © 2020 The Institute of Clinical Research. All Rights Reserved. Privacy Policy | Terms of Service